Using Host Defence Peptides to Fight Herpes Virus Infections
Author Information
Author(s): Jenssen Håvard
Primary Institution: Department of Science, Systems & Models, Roskilde University
Hypothesis
Can host defence peptides effectively combat herpes simplex virus infections?
Conclusion
Host defence peptides show promise as a new therapeutic approach against herpes simplex virus infections.
Supporting Evidence
- Host defence peptides can stimulate the innate immune system to combat infections.
- Some peptides have shown antiviral activity against both enveloped and non-enveloped viruses.
- Research indicates that these peptides may block viral entry by interacting with host cell receptors.
Takeaway
Scientists are exploring special proteins from our body that can help fight off herpes viruses, especially as some medicines are becoming less effective.
Methodology
This review discusses the antiviral activity of host defence peptides against herpes simplex virus and their potential clinical applications.
Limitations
The clinical application of host defence peptides is still in early stages, and more research is needed to fully understand their effectiveness.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website